Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 12

1.

Mucinous Carcinoma with Extensive Signet Ring Cell Differentiation: A Case Report.

Kim HM, Kim EK, Koo JS.

J Pathol Transl Med. 2017 Mar;51(2):176-179. doi: 10.4132/jptm.2016.08.17. Epub 2016 Dec 5.

2.

Clinicopathological Characteristics of Mucinous Breast Cancer: A Retrospective Analysis of a 10-Year Study.

Lei L, Yu X, Chen B, Chen Z, Wang X.

PLoS One. 2016 May 27;11(5):e0155132. doi: 10.1371/journal.pone.0155132. eCollection 2016.

3.

CDX-2, MUC-2 and B-catenin as intestinal markers in pure mucinous carcinoma of the breast.

García-Labastida L, Garza-Guajardo R, Barboza-Quintana O, Rodríguez-Sanchez IP, Ancer-Rodríguez J, Flores-Gutierrez JP, Gómez-Macías GS.

Biol Res. 2014 Sep 18;47:43. doi: 10.1186/0717-6287-47-43. Review.

4.

Mucinous breast cancer - clinical characteristics and treatment results in patients treated at the Oncology Centre in Kraków between 1952 and 2002.

Sas-Korczyńska B, Mituś J, Stelmach A, Ryś J, Majczyk A.

Contemp Oncol (Pozn). 2014;18(2):120-3. doi: 10.5114/wo.2014.42727. Epub 2014 Jun 3.

5.

Pure mucinous breast carcinoma: a favorable subtype.

Yang M, Li X, Chun-Hong P, Lin-Ping H.

Breast Care (Basel). 2013 Mar;8(1):56-9. doi: 10.1159/000346828.

6.

Risk factors for specific histopathological types of postmenopausal breast cancer in the NIH-AARP Diet and Health Study.

Nyante SJ, Dallal CM, Gierach GL, Park Y, Hollenbeck AR, Brinton LA.

Am J Epidemiol. 2013 Aug 1;178(3):359-71. doi: 10.1093/aje/kws471. Epub 2013 Jun 13.

7.

MicroRNA and histopathological characterization of pure mucinous breast carcinoma.

Zhou F, Li S, Meng HM, Qi LQ, Gu L.

Cancer Biol Med. 2013 Mar;10(1):22-7. doi: 10.7497/j.issn.2095-3941.2013.01.004.

8.

Evaluation of neoadjuvant chemotherapy response in women with locally advanced breast cancer using ultrasound elastography.

Falou O, Sadeghi-Naini A, Prematilake S, Sofroni E, Papanicolau N, Iradji S, Jahedmotlagh Z, Lemon-Wong S, Pignol JP, Rakovitch E, Zubovits J, Spayne J, Dent R, Trudeau M, Boileau JF, Wright FC, Yaffe MJ, Czarnota GJ.

Transl Oncol. 2013 Feb;6(1):17-24. Epub 2013 Feb 1.

9.

Resistance to trastuzumab in HER2-positive mucinous invasive ductal breast carcinoma.

Baretta Z, Guindalini RS, Khramtsova G, Olopade OI.

Clin Breast Cancer. 2013 Apr;13(2):156-8. doi: 10.1016/j.clbc.2012.11.007. Epub 2012 Dec 29. No abstract available.

10.

Pathological features of Breast Cancer seen in Northwestern Tanzania: a nine years retrospective study.

Rambau PF, Chalya PL, Manyama MM, Jackson KJ.

BMC Res Notes. 2011 Jun 22;4:214. doi: 10.1186/1756-0500-4-214.

11.

Absence of microsatellite instability in mucinous carcinomas of the breast.

Lacroix-Triki M, Lambros MB, Geyer FC, Suarez PH, Reis-Filho JS, Weigelt B.

Int J Clin Exp Pathol. 2010 Nov 27;4(1):22-31.

12.

Incidental breast lesions detected on CT: what is their significance?

Moyle P, Sonoda L, Britton P, Sinnatamby R.

Br J Radiol. 2010 Mar;83(987):233-40. doi: 10.1259/bjr/58729988. Epub 2009 Jun 22.

Supplemental Content

Support Center